PMC:7283670 / 107929-108198 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PD-FMA-UBERON

Id Subject Object Predicate Lexical cue fma_id
T16 37-45 Body_part denotes cytokine http://purl.org/sig/ont/fma/fma84050
T17 196-204 Body_part denotes cytokine http://purl.org/sig/ont/fma/fma84050

LitCovid-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T566 64-67 Disease denotes CRS http://purl.obolibrary.org/obo/MONDO_0007399|http://purl.obolibrary.org/obo/MONDO_0017361
T568 72-80 Disease denotes COVID‐19 http://purl.obolibrary.org/obo/MONDO_0100096
T569 191-195 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091

LitCovid-PD-CLO

Id Subject Object Predicate Lexical cue
T26 236-238 http://purl.obolibrary.org/obo/CLO_0050510 denotes 18

LitCovid-PD-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T72462 88-99 Chemical denotes tocilizumab http://purl.obolibrary.org/obo/CHEBI_64360

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T922 0-269 Sentence denotes Tocilizumab vs CRRT in management of cytokine release syndrome (CRS) in COVID‐19 Drug: tocilizumab, other: standard of care, procedure: continuous renal replacement therapy China, Covid‐19 SARS cytokine storm (and 2 more…) 120, all, 18–80 Observational Tocilizumab

LitCovid-PD-HP

Id Subject Object Predicate Lexical cue hp_id
T298 37-62 Phenotype denotes cytokine release syndrome http://purl.obolibrary.org/obo/HP_0033041
T299 196-210 Phenotype denotes cytokine storm http://purl.obolibrary.org/obo/HP_0033041